costap

Graduate health biotech trained executive. Constantly on lookout for very undervalued, unfairly trashed small biotechs with potential huge recovery with limited downside risk. Best on my list now:OMER ADMS EXEL DVAX TSRO SRNE NEOS ACHV. Anyone agree?